Skip to content

Drug interactions

Ondansetron + Pasireotide

Severity: Moderate

Ondansetron and Pasireotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide can cause bradycardia and QT prolongation, and ondansetron also prolongs the QT interval. Combined use increases arrhythmia risk.

What this interaction means in plain words

Ondansetron and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ondansetron belongs to Gastrointestinal Tract; Pasireotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive QT prolongation and bradycardic effects.

What to do

Obtain a baseline ECG and correct hypokalemia and hypomagnesemia. Monitor ECG during coadministration.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ondansetron and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ondansetron with Pasireotide?

MediHelp rates the interaction as moderate. Ondansetron and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide can cause bradycardia and QT prolongation, and ondansetron also prolongs the QT interval. Combined use increases arrhythmia risk.

How serious is the interaction between Ondansetron and Pasireotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct hypokalemia and hypomagnesemia. Monitor ECG during coadministration.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in